CDLX
NASDAQCardlytics Inc.
Price$0.60-3.00 (-33.29%)
2026-03-042026-06-05
News · 26 weeks43+29%
2025-12-142026-06-07
Mix2490d
- Insider10(42%)
- SEC Filings9(38%)
- Earnings3(13%)
- Other2(8%)
Latest news
25 items- SECCardlytics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Financial Statements and Exhibits8-K - Cardlytics, Inc. (0001666071) (Filer)
- INSIDERDirector Gupta Srishti A. converted options into 11,000 shares, increasing direct ownership by 179% to 17,148 units (SEC Form 4)4 - Cardlytics, Inc. (0001666071) (Issuer)
- INSIDERDirector Francis Jonathan Edward converted options into 11,000 shares, increasing direct ownership by 72% to 26,310 units (SEC Form 4)4 - Cardlytics, Inc. (0001666071) (Issuer)
- INSIDERDirector Hill Scott A converted options into 11,000 shares, increasing direct ownership by 19% to 68,748 units (SEC Form 4)4 - Cardlytics, Inc. (0001666071) (Issuer)
- INSIDERDirector Fernandez Andre J converted options into 11,000 shares, increasing direct ownership by 72% to 26,310 units (SEC Form 4)4 - Cardlytics, Inc. (0001666071) (Issuer)
- INSIDERDirector Hornsey Liane converted options into 11,000 shares, increasing direct ownership by 49% to 33,326 units (SEC Form 4)4 - Cardlytics, Inc. (0001666071) (Issuer)
- INSIDERDirector Klinck John L. Jr. converted options into 11,000 shares, increasing direct ownership by 14% to 89,593 units (SEC Form 4)4 - Cardlytics, Inc. (0001666071) (Issuer)
- SECCardlytics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Cardlytics, Inc. (0001666071) (Filer)
- INSIDERChief Financial Officer Evans David Thomas bought $129,000 worth of shares (200,000 units at $0.65), increasing direct ownership by 170% to 317,930 units (SEC Form 4)4 - Cardlytics, Inc. (0001666071) (Issuer)
- SECCardlytics Inc. filed SEC Form 8-K: Leadership Update8-K - Cardlytics, Inc. (0001666071) (Filer)
- SECSEC Form 10-Q filed by Cardlytics Inc.10-Q - Cardlytics, Inc. (0001666071) (Filer)
- SECCardlytics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Cardlytics, Inc. (0001666071) (Filer)
- PRCardlytics First Quarter 2026 Financial Results Driven By Strong Operational PerformanceCompany delivers strong first quarter results: Revenues from continuing operations $34.3 million; additional $4.2 million from Bridg discontinued operations Billings from continuing operations of $58.1 million; additional $4.2 million from Bridg discontinued operations Adjusted Contribution from continuing operations of $19.7 million; additional $3.6 million from Bridg discontinued operations Successfully completed the divestiture of Bridg on March 24, 2026 Subsequently liquidated PAR shares, further bolstering the balance sheet Cardlytics, Inc. (NASDAQ:CDLX), a commerce media platform, today announced financial results for the first quarter ended March 31, 2026. "The
- PRCardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Cardlytics, Inc. (NASDAQ:CDLX) today announced that on April 29, 2026, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 272,000 restricted stock units of Cardlytics to six newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement Plan (the "2022 Inducement Plan"). For all of the grant recipients, 50% of the restricted stock units shall vest on the first anniversary of the grant date, and the remaining 50% shall vest quarterly over the subsequent 12 months, subject to the employees' conti
- PRCORRECTING and REPLACING Cardlytics Announces Timing of Its First Quarter 2026 Earnings ReleaseLink to webcast in second bullet point (URL embedded behind phrase "this link") of release dated April 27, 2026 has been updated. The updated release reads: CARDLYTICS ANNOUNCES TIMING OF ITS FIRST QUARTER 2026 EARNINGS RELEASE Cardlytics, Inc. (NASDAQ:CDLX) today announced that its financial results for the first quarter ending March 31, 2026 will be released on May 7, 2026, after market close. Conference Call Details: When: May 7, 2026 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be availab
- PRCardlytics Announces Timing of Its First Quarter 2026 Earnings ReleaseCardlytics, Inc. (NASDAQ:CDLX) today announced that its financial results for the first quarter ending March 31, 2026 will be released on May 7, 2026, after market close. Conference Call Details: When: May 7, 2026 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be available on the website. About Cardlytics Cardlytics (NASDAQ:CDLX) is a commerce media platform, powered by our publishers' first-party purchase data, that makes commerce smarter and more rewarding for everyone. We offer a range of sol
- SECSEC Form DEFA14A filed by Cardlytics Inc.DEFA14A - Cardlytics, Inc. (0001666071) (Filer)
- SECSEC Form DEF 14A filed by Cardlytics Inc.DEF 14A - Cardlytics, Inc. (0001666071) (Filer)
- INSIDERSEC Form 4 filed by Gupta Amit4 - Cardlytics, Inc. (0001666071) (Issuer)
- INSIDERSEC Form 4 filed by Gupta Amit4 - Cardlytics, Inc. (0001666071) (Issuer)
- INSIDERSEC Form 4 filed by Lynton Nicholas Hollmeyer4 - Cardlytics, Inc. (0001666071) (Issuer)
- SECSEC Form PRE 14A filed by Cardlytics Inc.PRE 14A - Cardlytics, Inc. (0001666071) (Filer)
- SECCardlytics Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - Cardlytics, Inc. (0001666071) (Filer)
- PRCardlytics Completes Sale of Bridg Assets to PAR TechnologyCardlytics, Inc. (NASDAQ:CDLX), a digital advertising platform in banks' digital channels, today announced the closing of the previously announced sale of the Bridg business to PAR Technology Corporation (NYSE:PAR). Cardlytics will receive 1,810,222 shares of PAR Technology common stock as consideration for the sale of the Bridg assets. "The completion of this transaction marks an important milestone for Cardlytics," said Amit Gupta, Chief Executive Officer of Cardlytics. "Over the past several quarters, we have taken deliberate steps to sharpen our strategic focus and align our resources around the highest-impact opportunities in our business. With the sale of the Bridg assets, we are
- SECSEC Form S-8 filed by Cardlytics Inc.S-8 - Cardlytics, Inc. (0001666071) (Filer)
CDLX FAQ
7 questionsWhat does Cardlytics Inc. do?
Cardlytics, Inc. operates an advertising platform within financial institutions digital channels that include online, mobile, email, and various real-time notifications in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.Where does CDLX stock trade?
Cardlytics Inc. (CDLX) is listed on NASDAQ.What sector and industry is CDLX in?
Cardlytics Inc. operates in the Technology sector, Computer Software: Programming Data Processing industry.When did Cardlytics Inc. go public?
Cardlytics Inc. (CDLX) completed its IPO in 2018.What are analysts saying about CDLX?
Cardlytics Inc. has had 8 recent analyst actions on file. The most recent action was from Evercore ISI: In-line with a $400.00 price target on 2024-10-11. Recent price targets range from $350.00 to $1400.00.What companies are similar to CDLX?
Notable peers in the same industry include GOOGL (Alphabet Inc.), GOOG (Alphabet Inc.), META (Meta Platforms Inc.), APP (Applovin Corporation), NBIS (Nebius Group N.V.). Compare CDLX side-by-side with any of them on Quantisnow.How can I track CDLX on Quantisnow?
Quantisnow aggregates Cardlytics Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CDLX to receive live email and push alerts on every new disclosure.